stroke

AstraZeneca's Brilinta looks for label boost with trial win, priority review in stroke patients
AstraZeneca's Brilinta looks for label boost with trial win, priority review in stroke patients
Fierce Pharma
Brilinta
AstraZeneca
stroke
clinical trials
Flag link:
Tamping down stroke damage with a drug that protects brain cells
Tamping down stroke damage with a drug that protects brain cells
Fierce Biotech
TAT-DP-2
stroke
University of Pittsburgh
Flag link:
Startup using music to help stroke patients walk gets breakthrough designation
Startup using music to help stroke patients walk gets breakthrough designation
MedCity News
MedRhythms
stroke
rehab
FDA
breakthrough device
devices
Flag link:
AZ claims FDA okay for Brilinta in coronary artery disease patients
AZ claims FDA okay for Brilinta in coronary artery disease patients
Pharmaforum
AstraZeneca
Brilinta
FDA
heart attacks
stroke
coronary artery disease
Flag link:
Experts float Roche stroke drug Activase as potential COVID-19 therapy
Experts float Roche stroke drug Activase as potential COVID-19 therapy
Fierce Pharma
Roche
Genentech
Activase
stroke
COVID-19
Flag link:
J&J and Apple Begin Enrollment for Heartline Study
J&J and Apple Begin Enrollment for Heartline Study
Medical Devices and Diagnostics Industry
JNJ
iPhone
Apple
mobile apps
atrial fibrillation
stroke
devices
Flag link:
NoNO's Stroke Trial Could Have Major Implications for Future Treatment
NoNO's Stroke Trial Could Have Major Implications for Future Treatment
BioSpace
NoNO
clinical trials
stroke
nerinetide
Flag link:
Abbott Wins Approval for CATALYST Trial for At-Risk Stroke Patients
Abbott Wins Approval for CATALYST Trial for At-Risk Stroke Patients
Medical Devices and Diagnostics Industry
Abbott Labs
devices
stroke
atrial fibrillation
Amplatzer Amulet LAA
FDA
Flag link:
AstraZeneca makes case for use of blood thinner Brilinta in stroke patients
AstraZeneca makes case for use of blood thinner Brilinta in stroke patients
Endpoints
AstraZeneca
stroke
Brilinta
clinical trials
bloodthinners
Flag link:
Vizai hopes Medtronic deal will boost sales of its tech – and vice versa
Vizai hopes Medtronic deal will boost sales of its tech – and vice versa
EP Vantage
devices
stroke
Medtronic
Vizai
artificial intelligence
diagnostics
Flag link:
ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
Fierce Pharma
Eli Lilly
ADA
diabetes
heart attack
stroke
Trulicity
Novo Nordisk
semaglutide
Flag link:
AI-Based Stroke Rehab System Shown to Be as Effective as One-on-One Therapy
AI-Based Stroke Rehab System Shown to Be as Effective as One-on-One Therapy
Medical Devices and Diagnostics Industry
Motus Nova
theratainment
artificial intelligence
rehab
stroke
Flag link:
Pig brain tech could spur stroke therapies, drug and target validation
Pig brain tech could spur stroke therapies, drug and target validation
BioCentury
animal models
R&D
stroke
Flag link:
Acticor's blood thinner cuts hemorrhage risk in human study, could offer hope for acute stroke
Acticor's blood thinner cuts hemorrhage risk in human study, could offer hope for acute stroke
Fierce Biotech
Acticor
blood thinners
stroke
Flag link:
Microbiome Report for Week Ending 3/16/19
Microbiome Report for Week Ending 3/16/19
CP Wire
microbiome
Seres Therapeutics
AstraZeneca
stroke
Flag link:
Microbiome Report for Week Ending 3/16/19
microbiome
Seres Therapeutics
AstraZeneca
stroke
Flag link:
BioXyTran Files for $10 Million Offering to Advance Stroke and Wound Healing Candidates
BioXyTran Files for $10 Million Offering to Advance Stroke and Wound Healing Candidates
CP Wire
BioXyTran
stroke
Flag link:
11 innovative medical devices you need to know from 2018
11 innovative medical devices you need to know from 2018
Medical Design and Outsourcing
devices
Cerebrotech Visor
stroke
blood glucose monitoring
migraines
diagnostics
mobile apps
neurodegenerative disease
spectrometry
Flag link:
FDA hits Sanofi's struggling Lemtrada with new safety warning over reports of stroke, artery tears
FDA hits Sanofi's struggling Lemtrada with new safety warning over reports of stroke, artery tears
Fierce Pharma
Sanofi
Lemtrada
FDA
stroke
MS
Flag link:
Death Rates From Heart Disease And Stroke Could Be Significantly Less With These Drugs, Study Says
Death Rates From Heart Disease And Stroke Could Be Significantly Less With These Drugs, Study Says
Forbes
ESC 2018
stroke
heart disease
calcium channel blockers
statins
Flag link:

Pages